Phase I study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukaemia: maintaining immune functions during therapy-induced immunosuppression (Q87416299)
Jump to navigation
Jump to search
scientific article published on 09 October 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukaemia: maintaining immune functions during therapy-induced immunosuppression |
scientific article published on 09 October 2012 |
Statements
Phase I study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukaemia: maintaining immune functions during therapy-induced immunosuppression (English)
Sandra Eketorp Sylvan
Eva Rossmann
Anna Porwit
Stefan Norin
Claes Karlsson
Jeanette Lundin